Abstract
We studied 54 idiopathic Parkinson's disease (PD) patients with depressive disorders (DD) to compare the efficacy and the effect of treatment with sertraline in the usual formulation and in the liquid oral concentrate (LOC) formulation. After 6 months of sertraline treatment, the Hamilton Depression Rating Scale and the Montgomery and Asberg Depression Rating Scale showed a decrement (p <0.001, for both formulations). Parkinson's Disease Questionnaire scores improved (p <0.005 for usual formulation and p
| Original language | English |
|---|---|
| Pages (from-to) | 391-395 |
| Number of pages | 5 |
| Journal | Neurological Sciences |
| Volume | 29 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2008 |
Fingerprint
Keywords
- Depressive disorders
- Parkinson's disease
- Quality of life
- Sertraline
ASJC Scopus subject areas
- Dermatology
- Clinical Neurology
- Psychiatry and Mental health
Cite this
Sertraline in the treatment of depressive disorders in patients with Parkinson's disease. / Marino, Silvia; Sessa, Edoardo; Di Lorenzo, Giuseppe; Digangi, Giuseppina; Alagna, Antonella; Bramanti, Placido; Di Bella, Paolo.
In: Neurological Sciences, Vol. 29, No. 6, 2008, p. 391-395.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Sertraline in the treatment of depressive disorders in patients with Parkinson's disease
AU - Marino, Silvia
AU - Sessa, Edoardo
AU - Di Lorenzo, Giuseppe
AU - Digangi, Giuseppina
AU - Alagna, Antonella
AU - Bramanti, Placido
AU - Di Bella, Paolo
PY - 2008
Y1 - 2008
N2 - We studied 54 idiopathic Parkinson's disease (PD) patients with depressive disorders (DD) to compare the efficacy and the effect of treatment with sertraline in the usual formulation and in the liquid oral concentrate (LOC) formulation. After 6 months of sertraline treatment, the Hamilton Depression Rating Scale and the Montgomery and Asberg Depression Rating Scale showed a decrement (p <0.001, for both formulations). Parkinson's Disease Questionnaire scores improved (p <0.005 for usual formulation and p
AB - We studied 54 idiopathic Parkinson's disease (PD) patients with depressive disorders (DD) to compare the efficacy and the effect of treatment with sertraline in the usual formulation and in the liquid oral concentrate (LOC) formulation. After 6 months of sertraline treatment, the Hamilton Depression Rating Scale and the Montgomery and Asberg Depression Rating Scale showed a decrement (p <0.001, for both formulations). Parkinson's Disease Questionnaire scores improved (p <0.005 for usual formulation and p
KW - Depressive disorders
KW - Parkinson's disease
KW - Quality of life
KW - Sertraline
UR - http://www.scopus.com/inward/record.url?scp=58149102530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149102530&partnerID=8YFLogxK
U2 - 10.1007/s10072-008-1021-3
DO - 10.1007/s10072-008-1021-3
M3 - Article
C2 - 19002650
AN - SCOPUS:58149102530
VL - 29
SP - 391
EP - 395
JO - Neurological Sciences
JF - Neurological Sciences
SN - 1590-1874
IS - 6
ER -